寻找临床试验

寻找癌症试验

Search by keyword, study number, or principal investigator.

您搜索的是:

曼彻斯特

23个搜索结果

cfm

The Impact of Sharing Audio Recorded Clinic Visits on Self-Management in Older Adults: A Multi-site Trial

地点:曼彻斯特

Medicine-General 内科医学

Comparing 健康care visit Recording and Open Notes to Improve Chronic iLlness care Experience in older adults (the CHRONICLE Trial)

Location: 贝德福德, 曼彻斯特, 黎巴嫩

Medicine-Pulmonology

A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)

地点:曼彻斯特

一个多中心, 随机, 双盲, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

地点:曼彻斯特

A Phase 1 Study to Evaluate the Safety, 耐受性, and Pharmacokinetics of PTI-808 in 健康y Adult Subjects and in Adults with Cystic Fibrosis

地点:曼彻斯特

A第2期 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 in Subjects with Cystic Fibrosis who are Heterozygous for the F508del Mutation

地点:曼彻斯特

A第2期, 随机, 双盲 Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis

地点:曼彻斯特

A第3期, 非盲 Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis

Location: 黎巴嫩, 曼彻斯特

A第3期, 非盲 Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

地点:曼彻斯特

A第3期, 非盲, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation

地点:曼彻斯特

A第3期, 随机, 双盲, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)

地点:曼彻斯特

A第3期, 随机, 双盲, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

地点:曼彻斯特

A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects with Cystic Fibrosis of Chronic Pancreatitis Treated with Creon (Pancrelipase) with an Alternate Source of Active Pharmaceutical Ingredient

地点:曼彻斯特

An Observational Long-Term Safety Surveillance of Participants from Corbus Sponsored Lenabasum Pivotal Clinical Trials

地点:曼彻斯特

Cystic Fibrosis Foundation Patient Registry

Location: 贝德福德, 曼彻斯特, 黎巴嫩

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

地点:曼彻斯特, 黎巴嫩

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis

Location: 黎巴嫩, 曼彻斯特

The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes

地点:曼彻斯特, 黎巴嫩

Pediatrics/Adolescent Medicine-General Pediatrics

The Developing Infant: Mapping the Microbiome in 健康 and in Disease

Location: 贝德福德, 曼彻斯特, 黎巴嫩

Using patient data to transform care and improve outcomes for children, 青少年, and young adults with Inflammatory Bowel Disease

地点:曼彻斯特, 黎巴嫩

Vitamin D Oral Replacement in Asthma

地点:曼彻斯特

Pediatrics/Adolescent Medicine-Pediatric Pulmonology

A Prospective Observational Study in Cystic Fibrosis 病人 With Chronic Respiratory Pseudomonas Aeruginosa Infection Treated With TOBI Podhaler (Tobramycin Inhalation Powder) or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

地点:曼彻斯特

精神病学

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

地点:曼彻斯特

寻找癌症试验? 访问我们的癌症网站.